Paper29263263
Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X and 10 others. J Virol, 2018. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses. Papers, record 29263263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29263263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation | Major topic |
| Coronavirus | Major topic |
| Membrane Proteins | Major topic |
| Mutation, Missense | Major topic |
| Protein Multimerization | Major topic |
| RNA-Binding Proteins | Major topic |
| Virus Internalization | Major topic |
| Amino Acid Motifs | |
| Amino Acid Substitution | |
| Cell Line, Tumor | |
| Humans | |
| Spike Glycoprotein, Coronavirus |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI113267 | NIAID NIH HHS | United States | R01AI113267 | PubMed and NIH |
Source NIH RePORTER
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24521078 | Identification of an endocytic signal essential for the antiviral action of IFITM3. | Cell Microbiol | 2014 | https://conductscience.org/library/papers/24521078 | PubMed |
| 2 | 27384652 | The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. | J Virol | 2016 | https://conductscience.org/library/papers/27384652 | PubMed |
| 3 | 25552713 | Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment. | J Virol | 2015 | https://conductscience.org/library/papers/25552713 | PubMed |
| 4 | 22633075 | Viral and host control of cytomegalovirus maturation. | Trends Microbiol | 2012 | https://conductscience.org/library/papers/22633075 | PubMed |
| 5 | 23072881 | The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy. | Antiviral Res | 2012 | https://conductscience.org/library/papers/23072881 | PubMed |
| 6 | 23075143 | Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23075143 | PubMed |
| 7 | 25256397 | IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. | Viruses | 2014 | https://conductscience.org/library/papers/25256397 | PubMed |
| 8 | 7474080 | Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. | J Virol | 1995 | https://conductscience.org/library/papers/7474080 | PubMed |
| 9 | 25599080 | IFITM-Family Proteins: The Cell's First Line of Antiviral Defense. | Annu Rev Virol | 2014 | https://conductscience.org/library/papers/25599080 | PubMed |
| 10 | 23720721 | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. | J Virol | 2013 | https://conductscience.org/library/papers/23720721 | PubMed |
| 11 | 25187545 | Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. | J Virol | 2014 | https://conductscience.org/library/papers/25187545 | PubMed |
| 12 | 23536651 | TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. | J Virol | 2013 | https://conductscience.org/library/papers/23536651 | PubMed |
| 13 | 23658454 | The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. | J Virol | 2013 | https://conductscience.org/library/papers/23658454 | PubMed |
| 14 | 18077728 | Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. | J Virol | 2008 | https://conductscience.org/library/papers/18077728 | PubMed |
| 15 | 27440901 | The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses. | J Virol | 2016 | https://conductscience.org/library/papers/27440901 | PubMed |
| 16 | 20601941 | Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. | Nat Chem Biol | 2010 | https://conductscience.org/library/papers/20601941 | PubMed |
| 17 | 26263374 | E3 Ubiquitin Ligase NEDD4 Promotes Influenza Virus Infection by Decreasing Levels of the Antiviral Protein IFITM3. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/26263374 | PubMed |
| 18 | 24217413 | A decade after SARS: strategies for controlling emerging coronaviruses. | Nat Rev Microbiol | 2013 | https://conductscience.org/library/papers/24217413 | PubMed |
| 19 | 22996292 | IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. | Hepatology | 2013 | https://conductscience.org/library/papers/22996292 | PubMed |
| 20 | 24627473 | Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24627473 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42707764 | IFITM3 at the viral fusion-pore checkpoint: membrane energetics and entry-route-dependent outcomes. | Front Immunol | 2026 | https://conductscience.org/library/papers/42707764 | PubMed |
| 42180258 | Interferon-induced transmembrane proteins: membrane gatekeepers of fusion and infection. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42180258 | PubMed |
| 41940670 | Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4. | J Virol | 2026 | https://conductscience.org/library/papers/41940670 | PubMed |
| 41846946 | The zinc metalloprotease ZMPSTE24 binds a distinct topological isoform of the tail-anchored protein IFITM3. | bioRxiv | 2026 | https://conductscience.org/library/papers/41846946 | PubMed |
| 39724110 | Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39724110 | PubMed |
| 39501328 | IFITM1 is a host restriction factor that inhibits porcine epidemic diarrhea virus infection. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39501328 | PubMed |
| 39459876 | Research Progress into the Biological Functions of IFITM3. | Viruses | 2024 | https://conductscience.org/library/papers/39459876 | PubMed |
| 39228892 | Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39228892 | PubMed |
| 38560173 | Identification of receptors and factors associated with human coronaviruses in the oral cavity using single-cell RNA sequencing. | Heliyon | 2024 | https://conductscience.org/library/papers/38560173 | PubMed |
| 38258394 | CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function. | Innate Immun | 2024 | https://conductscience.org/library/papers/38258394 | PubMed |
| 38140570 | Discovery and Characterization of IFITM S-Palmitoylation. | Viruses | 2023 | https://conductscience.org/library/papers/38140570 | PubMed |
| 37985854 | SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks". | Cell Mol Immunol | 2024 | https://conductscience.org/library/papers/37985854 | PubMed |
| 37763019 | SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication. | J Clin Med | 2023 | https://conductscience.org/library/papers/37763019 | PubMed |
| 37676001 | Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry. | J Virol | 2023 | https://conductscience.org/library/papers/37676001 | PubMed |
| 37382452 | Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4). | mBio | 2023 | https://conductscience.org/library/papers/37382452 | PubMed |
| 37252940 | IFITM1 enhances nonenveloped viral RNA replication by facilitating cholesterol transport to the Golgi. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37252940 | PubMed |
| 37239983 | Ethyl Gallate Inhibits Bovine Viral Diarrhea Virus by Promoting IFITM3 Expression, Lysosomal Acidification and Protease Activity. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239983 | PubMed |
| 37119412 | Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37119412 | PubMed |
| 36992136 | Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36992136 | PubMed |
| 36970857 | Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunity. | EMBO J | 2023 | https://conductscience.org/library/papers/36970857 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFITM1 | 8519 | PubTator's text mining | https://conductscience.org/library/genes/8519 | NCBI Gene |
| IFITM2 | 10581 | PubTator's text mining | https://conductscience.org/library/genes/10581 | NCBI Gene |
| IFITM3 | 10410 | PubTator's text mining | https://conductscience.org/library/genes/10410 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29263263
GET https://conductscience.org/api/papers/v1/29263263/references?page=2